{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T15:22:03Z","timestamp":1778685723036,"version":"3.51.4"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,9,1]],"date-time":"1985-09-01T00:00:00Z","timestamp":494380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch. Pharmacol."],"published-print":{"date-parts":[[1985,9]]},"DOI":"10.1007\/bf00572436","type":"journal-article","created":{"date-parts":[[2004,11,20]],"date-time":"2004-11-20T17:31:33Z","timestamp":1100971893000},"page":"212-221","source":"Crossref","is-referenced-by-count":127,"title":["Xanthine derivatives as antagonists at A1 and A2 adenosine receptors"],"prefix":"10.1007","volume":"330","author":[{"given":"U.","family":"Schwabe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ukena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. J.","family":"Lohse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","first-page":"400","volume":"13","author":"T Asano","year":"1977","unstructured":"Asano T, Ochiai Y, Hidaka H (1977) Selective inhibition of separated forms of human platelet cyclic nucleotide phosphodiesterase by platelet aggregation inhibitors. Mol Pharmacol 13: 400?406","journal-title":"Mol Pharmacol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1016\/S0021-9258(19)41269-6","volume":"250","author":"AJ Blume","year":"1975","unstructured":"Blume AJ, Foster CJ (1975) Mouse neuroblastoma adenylate cyclase. Adenosine and adenosine analogues as potent effectors of adenylate cyclase activity. J Biol Chem 250: 5003?5008","journal-title":"J Biol Chem"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0006-2952(81)90062-9","volume":"30","author":"RF Bruns","year":"1981","unstructured":"Bruns RF (1981) Adenosine antagonism by purines, pteridines and benzopteridines in human fibroblasts. Biochem Pharmacol 30: 325?333","journal-title":"Biochem Pharmacol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.77.9.5547","volume":"77","author":"RF Bruns","year":"1980","unstructured":"Bruns RF, Daly JW, Snyder SH (1980) Adenosine receptors in brain membranes: Binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine. Proc Natl Acad Sci USA 77: 5547?5551","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1073\/pnas.80.7.2077","volume":"80","author":"RF Bruns","year":"1983","unstructured":"Bruns RF, Daly JW, Snyder SH (1983) Adenosine receptor binding: Structure-activity analysis generates extremely potent xanthine antagonists. Proc Natl Acad Sci USA 80: 2077?2080","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","volume":"22","author":"YC Cheng","year":"1973","unstructured":"Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (K i) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099?3108","journal-title":"Biochem Pharmacol"},{"key":"CR7","first-page":"598","volume":"18","author":"DMF Cooper","year":"1980","unstructured":"Cooper DMF, Londos C, Rodbell M (1980) Adenosine receptor-mediated inhibition of rat cerebral cortical adenylate cyclase by a GTP-dependent process. Mol Pharmacol 18: 598?601","journal-title":"Mol Pharmacol"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1476-5381.1981.tb10995.x","volume":"72","author":"NJ Cusack","year":"1981","unstructured":"Cusack NJ, Hourani SMO (1981) 5?-N-Ethylcarboxamidoadenosine: A potent inhibitor of human platelet aggregation. Br J Pharmacol 72: 443?447","journal-title":"Br J Pharmacol"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/jm00345a001","volume":"25","author":"JW Daly","year":"1982","unstructured":"Daly JW (1982) Adenosine receptors: Targets for future drugs. J Med Chem 25: 197?207","journal-title":"J Med Chem"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0165-6147(79)90046-4","volume":"1","author":"BB Fredholm","year":"1980","unstructured":"Fredholm BB (1980) Are methylxanthine effects due to antagonism of endogenous adenosine? Trends Pharmacol Sci 1: 129?132","journal-title":"Trends Pharmacol Sci"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0014-2999(82)90359-4","volume":"81","author":"BB Fredholm","year":"1982","unstructured":"Fredholm BB, Persson CGA (1982) Xanthine derivatives as adenosine receptor antagonists. Eur J Pharmacol 81: 673?676","journal-title":"Eur J Pharmacol"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1021\/jm00376a027","volume":"27","author":"RA Glennon","year":"1984","unstructured":"Glennon RA, Tejani-Butt SM, Padgett W, Daly JW (1984) Mesoionic xanthine analogues: Antagonists of adenosine receptors. J Med Chem 27: 1364?1367","journal-title":"J Med Chem"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0014-2999(81)90346-0","volume":"75","author":"SG Griffith","year":"1981","unstructured":"Griffith SG, Meghji P, Moody CJ, Burnstock G (1981) 8-Phenyltheophylline: A potent P1-purinoceptor antagonist. Eur J Pharmacol 75: 61?64","journal-title":"Eur J Pharmacol"},{"key":"CR14","first-page":"528","volume":"11","author":"RJ Haslam","year":"1975","unstructured":"Haslam RJ, Rosson GM (1975) Effects of adenosine on levels of adenosine cyclic 3?,5?-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation. Mol Pharmacol 11: 528?544","journal-title":"Mol Pharmacol"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/BF00495948","volume":"325","author":"E H\u00fcttemann","year":"1984","unstructured":"H\u00fcttemann E, Ukena D, Lenschow V, Schwabe U (1984)R a Adenosine receptors in human platelets. Characterization by 5?-N-ethylcarboxamido[3H]adenosine binding in relation to adenylate cyclase activity. Naunyn-Schmiedeberg's Arch Pharmacol 325: 226?233","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR16","first-page":"381","volume":"2","author":"KH Jakobs","year":"1976","unstructured":"Jakobs KH, Saur W, Schultz G (1976) Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine. J Cyclic Nucl Res 2: 381?392","journal-title":"J Cyclic Nucl Res"},{"key":"CR17","first-page":"1","volume":"26","author":"MJ Lohse","year":"1984","unstructured":"Lohse MJ, Lenschow V, Schwabe U (1984) Two affinity states ofR i adenosine receptors in brain membranes. Analysis of guanine nucleotide and temperature effects on radioligand binding. Mol Pharmacol 26: 1?9","journal-title":"Mol Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"5362","DOI":"10.1073\/pnas.75.11.5362","volume":"75","author":"C Londos","year":"1978","unstructured":"Londos C, Cooper DMF, Schlegel W, Rodbell M (1978) Adenosine analogs inhibit adipocyte adenylate cyclase by a GTP-dependent process: Basis for actions of adenosine and methylxanthines on cyclic AMP production and lipolysis. Proc Natl Acad Sci USA 75: 5362?5366","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1073\/pnas.77.5.2551","volume":"77","author":"C Londos","year":"1980","unstructured":"Londos C, Cooper DMF, Wolff J (1980) Subclasses of external adenosine receptors. Proc Natl Acad Sci USA 77: 2551?2554","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265?275","journal-title":"J Biol Chem"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.44.2.417","volume":"44","author":"DW McKeel","year":"1970","unstructured":"McKeel DW, Jarett L (1970) Preparation and characterization of a plasma membrane fraction from isolated fat cells. J Cell Biol 44: 417?432","journal-title":"J Cell Biol"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0021-9258(18)51687-2","volume":"239","author":"M Rodbell","year":"1964","unstructured":"Rodbell M (1964) Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239: 375?380","journal-title":"J Biol Chem"},{"key":"CR23","first-page":"R37","volume":"Suppl 329","author":"U Schwabe","year":"1985","unstructured":"Schwabe U (1985) Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn-Schmiedeberg's Arch Pharmacol Suppl 329: R37","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/BF00508080","volume":"273","author":"U Schwabe","year":"1972","unstructured":"Schwabe U, Berndt S, Ebert R (1972) Activation and inhibition of lipolysis in isolated fat cells by various inhibitors of cyclic AMP phosphodiesterase. Naunyn-Schmiedeberg's Arch Pharmacol 273: 62?74","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00505731","volume":"313","author":"U Schwabe","year":"1980","unstructured":"Schwabe U, Trost T (1980) Characterization of adenosine receptors in rat brain by (?)[3H]N6-phenylisopropyladenosine. Naunyn-Schmiedeberg's Arch Pharmacol 313: 179?187","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/0024-3205(79)90458-2","volume":"24","author":"FW Smellie","year":"1979","unstructured":"Smellie FW, Davis CW, Daly JW, Wells JN (1979) Alkylxanthines: Inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity. Life Sci 24: 2475?2482","journal-title":"Life Sci"},{"key":"CR27","first-page":"228","volume":"19","author":"T Trost","year":"1981","unstructured":"Trost T, Schwabe U (1981) Adenosine receptors in fat cells. Identification by (?)-N6-[3H]-phenylisopropyladenosine binding. Mol Pharmacol 19: 228?235","journal-title":"Mol Pharmacol"},{"key":"CR28","first-page":"61","volume":"16","author":"BS Tsai","year":"1979","unstructured":"Tsai BS, Lefkowitz RJ (1979) Agonist-specific effects of guanine nucleotides on alpha-adrenergic receptors in human platelets. Mol Pharmacol 16: 61?68","journal-title":"Mol Pharmacol"},{"key":"CR29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/276839a0","volume":"276","author":"D Calker Van","year":"1978","unstructured":"Van Calker D, M\u00fcller M, Hamprecht B (1978) Adenosine inhibits the accumulation of cyclic AMP in cultured brain cells. Nature 276: 839?841","journal-title":"Nature"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0005-2787(79)90122-9","volume":"526","author":"TF Walseth","year":"1979","unstructured":"Walseth TF, Johnson RA (1979) The enzymatic preparation of [?-32P]nucleoside triphosphates, cyclic [32P]AMP, and cyclic [32P]GMP. Biochim Biophys Acta 526: 11?31","journal-title":"Biochim Biophys Acta"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4899-7321-4_14","volume-title":"Handbook of neurochemistry, vol 2","author":"VP Whittaker","year":"1969","unstructured":"Whittaker VP (1969) The synaptosome. In: Lajtha A (ed) Handbook of neurochemistry, vol 2. Plenum Press, New York, pp 327?364"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"6892","DOI":"10.1073\/pnas.77.11.6892","volume":"77","author":"M Williams","year":"1980","unstructured":"Williams M, Risley EA (1980) Biochemical characterization of putative central purinergic receptors by using 2-chloro[3H]-adenosine, a stable analog of adenosine. Proc Natl Acad Sci USA 77: 6892?6896","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/0024-3205(82)90676-2","volume":"31","author":"PH Wu","year":"1982","unstructured":"Wu PH, Phillis JW, Nye MJ (1982) Alkylxanthines as adenosine receptor antagonists and membrane phosphodiesterase inhibitors in central nervous tissue: Evaluation of structure-activity relationships. Life Sci 31: 2857?2876","journal-title":"Life Sci"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00572436.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00572436\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00572436","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T07:19:39Z","timestamp":1624951179000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00572436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985,9]]}},"alternative-id":["BF00572436"],"URL":"https:\/\/doi.org\/10.1007\/bf00572436","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,9]]}}}